PRICES include / exclude VAT
Homepage>BS Standards>11 HEALTH CARE TECHNOLOGY>11.040 Medical equipment>11.040.40 Implants for surgery, prosthetics and orthotics>BS ISO 13781:2017 Implants for surgery. Homopolymers, copolymers and blends on poly(lactide). In vitro degradation testing
immediate downloadReleased: 2017-08-03
BS ISO 13781:2017 Implants for surgery. Homopolymers, copolymers and blends on poly(lactide). In vitro degradation testing

BS ISO 13781:2017

Implants for surgery. Homopolymers, copolymers and blends on poly(lactide). In vitro degradation testing

Format
Availability
Price and currency
English Secure PDF
Immediate download
270.40 USD
You can read the standard for 1 hour. More information in the category: E-reading
Reading the standard
for 1 hour
27.04 USD
You can read the standard for 24 hours. More information in the category: E-reading
Reading the standard
for 24 hours
81.12 USD
English Hardcopy
In stock
270.40 USD
Standard number:BS ISO 13781:2017
Pages:24
Released:2017-08-03
ISBN:978 0 580 85741 6
Status:Standard
DESCRIPTION

BS ISO 13781:2017


This standard BS ISO 13781:2017 Implants for surgery. Homopolymers, copolymers and blends on poly(lactide). In vitro degradation testing is classified in these ICS categories:
  • 11.040.40 Implants for surgery, prosthetics and orthotics

This document describes methods for the determination of chemical and mechanical changes in poly(lactide)-based homopolymers, copolymers and/or blends induced under in vitro degradation testing conditions. This document covers polymers based on L-lactide, D-lactide, and/or D, L-lactide monomeric units.

The purpose of this document is to compare and/or evaluate materials or processing conditions. This document also describes the fundamental physical and mechanical evaluations needed for an in vitro degradation characterization of an absorbable poly(lactide) or other hydrolysable material or device.

This document is applicable to poly(lactide)-based homopolymers, copolymers and/or blends in bulk or processed forms and used for the manufacture of surgical implants, including finished products (packaged and sterilized implants).

The test methods specified in this document are also intended to determine the in vitro degradation rate and related changes in material properties of polylactide-based copolymers and/or blends with various other comonomers, such as glycolid, trimethylene, carbonate and/or ε-caprolactone. Unless otherwise validated for a specific device, these in vitro methods cannot be used to definitively predict device behaviour under in vivo conditions.